Age 65–79 years at T1 | Age ≥ 80 years at T1 | Total | |||||
---|---|---|---|---|---|---|---|
Women | Men | Total | Women | Men | Total | ||
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Participants | 94 (100) | 113 (100) | 207 (100) | 149 (100) | 128 (100)a, b | 277 (100) c | 484 (100) |
Mortality | |||||||
Year 1 | 10 (10.64) | 14 (12.39) | 24 (11.59) | 24 (16.11) | 37 (28.90) | 62 (22.38) | 86 (18.18) |
Year 2 | 7 (7.45) | 5 (4.42) | 12 (5.80) | 16 (10.74) | 16 (12.50) | 32 (11.55) | 44 (9.09) |
Year 3 | 7 (7.45) | 5 (4.42) | 12 (5.80) | 14 (9.40) | 16 (12.50) | 30 (10.83) | 42 (8.68) |